Alembic Pharma Q3 Results: Company posts 23% YoY decline in net profit at Rs 138 crore, revenue up 4%

Drug maker Alembic Pharma on Monday reported Rs 138 crore net profit in Q3FY25, which is 23% year-on-year (YoY) decline compared to corresponding period of previous year, led by lacklustre growth in India business due to headwinds in the acute segment, despite strong sales growth in US and…